CDC: Proportion of extensively drug-resistant Shigella isolates increasing
medicalxpress - The proportion of extensively drug-resistant (XDR) Shigella isolates in the United States increased from 2011–2015 to 2023, according to research published in the April 9 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality…
AI Summary: Federal health officials report a worrying uptick in extensively drug‑resistant Shigella strains, complicating treatment and raising the risk of harder‑to‑control outbreaks. The data underscore the need for enhanced surveillance, hygiene measures, antibiotic stewardship and rapid public‑health responses as standard antibiotics lose reliability. Try not to spread it—literally.
Should you really trust health advice from an AI chatbot?
bbc - Abi has had very mixed results when asking a chatbot for guidance about her health issues.
AI Summary: Recent analyses and a hospital study reveal mainstream AI chatbots frequently provide incorrect or misleading medical guidance and miss initial diagnoses, posing real patient‑safety risks. The research shows these systems can fabricate facts, overconfidently assert dubious recommendations and fail to flag uncertainty, prompting calls for clinician oversight, clearer warnings and tighter evaluation before trusting bots with health decisions.
- Chatbots misdiagnose and confidently give dangerous medical advice (4)
- Companies race to build clinical AI tools and invest heavily (4)
- Other AI healthcare stories: innovation, payers, workflows, mental health trials (12)
- Researchers demand proof and robust evaluation before clinical AI deployment (5)
- Utah pilots bold AI medical programs, sparking safety debates (3)
- All Other Stories
Chatbots misdiagnose and confidently give dangerous medical advice
Companies race to build clinical AI tools and invest heavily
Other AI healthcare stories: innovation, payers, workflows, mental health trials
Researchers demand proof and robust evaluation before clinical AI deployment
Utah pilots bold AI medical programs, sparking safety debates
All Other Stories
Three gene therapy pioneers just won the Breakthrough Prize. This is their story
Ryan Cross / endpoints - A trio of scientists behind the first gene therapy approved in the United States have been awarded a Breakthrough Prize in Life Sciences. It’s arguably one of the most prominent recognitions yet for the field ...
AI Summary: Three gene‑therapy researchers received the Breakthrough Prize in recognition of foundational work that enabled the first CRISPR-based sickle cell therapy. The award highlights decades of basic and translational research that turned genome editing from lab curiosity into a tangible clinical remedy, with winners sharing a multimillion‑dollar prize and public acclaim.
Growing liver tissue directly in the body could ease donor organ shortage
medicalxpress - In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary regenerative capacity to repair or compensate for it. Once this "point of no return" has been reached, the only option is an organ tran…
AI Summary: Scientists report a technique to grow liver tissue directly inside the body as a potential solution to donor organ shortages, demonstrating functional hepatic tissue formation in preclinical or early clinical models. The promising results have been followed by an editorial expression of concern over methodology and data, prompting calls for independent validation before wider clinical use.
Eating more fruits and vegetables tied to unexpected lung cancer risk
sciencedaily - A surprising new study suggests that eating a very healthy diet—packed with fruits, vegetables, and whole grains—might be linked to a higher risk of lung cancer in younger non-smokers. Researchers found that patients under 50 diagnosed with lung cancer of…
AI Summary: A new analysis links higher fruit-and-vegetable consumption to an unexpected rise in lung cancer risk among younger non‑smokers, with investigators pointing to pesticide residues on produce as a likely culprit. Researchers urge careful interpretation—don’t ditch your salad—while calling for stricter residue limits, better monitoring, and further study to untangle diet, toxins, and cancer risk.
700-year-old mummy from Bolivia contains earliest confirmed evidence of strep throat bacteria in the Americas
livescience - A DNA analysis of pathogens from a pre-Hispanic mummy revealed that the bacterium that causes scarlet fever and strep throat was present in the Americas prior to European colonization.
AI Summary: Ancient DNA recovered from a 700‑year‑old Bolivian mummy has identified Streptococcus pyogenes—pathogen that can cause strep throat and scarlet fever—providing the earliest confirmed evidence of the bacteria in the Americas. Genomic analysis shows the bacterium was present well before European contact, reshaping timelines of infectious disease history and prompting fresh questions about pre‑Columbian pathogen ecology.
FDA updates mifepristone safety study status
Ella Jeffries / beckershospitalreview - The FDA updated its mifepristone guidance, detailing ongoing work on a safety study and the current status of the drug’s Risk Evaluation and Mitigation Strategy program. According to an April 8 news release, the agency said it is still collecting and eval…
AI Summary: The FDA updated the safety review status for mifepristone, yet the regulatory change hasn’t translated into widespread retail availability. Many community pharmacies are still hesitant to dispense the drug due to logistical, legal and reputational concerns, leaving access limited despite federal moves intended to broaden distribution — so yes, policy changed, but practice lagged.
'I'm not being listened to' - new health plan launched as women say they are still ignored
bbc - New plans to improve healthcare for women and girls have been set out, but will they change anything?
AI Summary: Health officials unveiled a new women's health plan, but many women say the rollout feels performative and that their concerns remain unheard. Patient advocates warn the initiative risks repeating past mistakes unless it embeds lived experience, transparent accountability and genuine co-design—otherwise it's policy theater with a glossy brochure.
Florida surgeon charged with manslaughter after removing wrong organ
Mariah Taylor / beckershospitalreview - Thomas Shaknovsky, MD, a Florida surgeon, was charged April 13 with second-degree manslaughter in connection with the death of a 70-year-old man during surgery. The Alabama man was vacationing in Florida when he experienced severe pain on his left side, T…
AI Summary: A Florida surgeon has been criminally charged with manslaughter after allegedly removing the wrong organ during an operation that resulted in a patient’s death. Prosecutors say the error was catastrophic, triggering an investigation and renewed scrutiny of surgical safety protocols, oversight practices, and how a single clinical mistake escalates into a criminal case.
AACR Announces 2026 Distinguished Service Award Recipients
oncodaily - The American Association for Cancer Research (AACR) has announced the recipients of its 2026 Distinguished Service Awards, recognizing individuals whose work has shaped the direction of cancer research, policy, and […]
AI Summary: The American Association for Cancer Research announced its 2026 Distinguished Service Award recipients, honoring leaders for exceptional contributions to cancer research, advocacy, and public engagement. The prizes celebrate scientific leadership across academia, clinical practice, and patient advocacy, reinforcing AACR’s priorities while handing the field a roster of role models to admire—and occasionally envy.
- Awards & grants: Distinguished Service, Trailblazers, scholar honors (4)
- Clinical highlights: Trials, company data, and therapeutic developments (5)
- On-site coverage: Live updates, press conferences, and recaps (4)
- Other: Attendee reflections and unrelated items (5)
- All Other Stories
Awards & grants: Distinguished Service, Trailblazers, scholar honors
Clinical highlights: Trials, company data, and therapeutic developments
On-site coverage: Live updates, press conferences, and recaps
Other: Attendee reflections and unrelated items
All Other Stories
Mount Sinai, Anthem reach 3-year agreement
Elizabeth Casolo / beckershospitalreview - Anthem Blue Cross Blue Shield in New York and New York City-based Mount Sinai Health System have established a three-year agreement, both organizations confirmed to Becker’s. The agreement includes hospitals, physicians and other providers. Mount Sinai sa…
AI Summary: Mount Sinai and Anthem reached a three‑year contract restoring in‑network coverage after negotiations, ending a period of uncertainty for patients and clinicians. The deal averts immediate network disruption and signals both sides' willingness to settle—proof that combat can end in compromise when hospitals and insurers remember patients actually use the services.
Baylor Scott & White Health Plan to exit Medicaid, individual markets; cut 321 jobs
Jakob Emerson / beckershospitalreview - Baylor Scott & White Health Plan said April 14 it will exit the Texas Medicaid managed care market and discontinue its individual marketplace plans, affecting roughly 225,000 members and eliminating 321 jobs statewide, according to the Dallas Morning News…
AI Summary: Baylor Scott & White announced it will leave Medicaid individual markets, a move that will shed hundreds of jobs and reshape coverage options for affected enrollees. The decision highlights ongoing financial pressures in public‑program participation and raises practical concerns about access continuity for people reliant on those plans.
Norway's 'Oslo patient' reaches HIV remission after rare stem cell transplant donated by brother
medicalxpress - A Norwegian man has been effectively cured of HIV after receiving a stem cell transplant from his brother, doctors announced on Monday.
AI Summary: A remarkable clinical case: a patient in Norway known as the "Oslo patient" has entered sustained HIV remission following a rare stem‑cell transplant from a donor with genetic resistance to the virus. The outcome offers cautious optimism for curative strategies, though experts stress this remains an exceptional, high‑risk intervention rather than a broadly applicable cure.
One lot of Xanax recalled nationwide over quality issue, FDA says
medicalxpress - A widely used anxiety medication is being pulled from shelves due to "failed dissolution specifications," the U.S. Food and Drug Administration (FDA) said.
AI Summary: Regulators have flagged a quality issue and a manufacturer has recalled a specific lot of Xanax nationwide. Pharmacies and patients have been advised to check lot numbers and return affected pills; health officials emphasize the recall is precautionary, urging anyone with concerns to consult their pharmacist or clinician rather than panic-buy substitutes.
FDA to review whether to allow more access to certain peptides
medicalxpress - The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.
AI Summary: The FDA is moving toward expanding access to certain compounded peptides, opening a regulatory review that could loosen limits on how pharmacies and clinics obtain and prepare these popular therapies. The review balances potential patient demand and shortages against safety and quality-control concerns, putting compounding practices squarely under the spotlight.
Anti-amyloid Alzheimer's drugs show no clinically meaningful effect
medicalxpress - Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new review in the Cochrane Database of Systematic Reviews has found.
AI Summary: A major review concludes anti-amyloid Alzheimer’s medications show no clinically meaningful effect on patients’ cognition or daily function, prompting renewed debate about drug approvals, prescribing and research priorities. The analysis calls for careful reassessment of treatment value, clearer communication to patients and tighter scrutiny of future trials.
- Anti-amyloid drugs fall short: little benefit, safety risks (5)
- New biomarkers and imaging reshape Alzheimer’s diagnosis timing (3)
- Social and care issues: loneliness, memory and treatment decisions (2)
- All Other Stories
Anti-amyloid drugs fall short: little benefit, safety risks
New biomarkers and imaging reshape Alzheimer’s diagnosis timing
Social and care issues: loneliness, memory and treatment decisions
All Other Stories
New Bill Seeks to Lower Out-of-Pocket Drug Costs
Marissa Plescia / medcitynews - Rep. Greg Murphy introduced a bill that would require out-of-pocket prescription drug spending to count toward patients’ deductibles and out-of-pocket maximums regardless of where the drugs are purchased.The post New Bill Seeks to Lower Out-of-Pocket Drug…
AI Summary: Lawmakers introduced legislation to reduce out‑of‑pocket drug costs by allowing patients' direct drug purchases to count toward their insurance deductibles. The proposal aims to ease financial strain for people buying costly medications out‑of‑pocket, but would require insurers and pharmacy systems to change longstanding accounting and benefits practices.
American Cancer Society Announces New Pediatric, Adolescent, and Young Adult Cancer Journal; Names Editor-in-Chief
cancer - The publication will provide a platform to share discoveries and advance knowledge across the field of pediatric and AYA oncology
AI Summary: The American Cancer Society launched a new open‑access journal dedicated to pediatric, adolescent and young adult oncology and named its inaugural editor‑in‑chief. The journal aims to centralize research, clinical guidance and policy discussions for younger patients, speeding dissemination of age‑specific evidence and, one hopes, improving outcomes for a frequently overlooked group.
- ACS launches open‑access journal centralizing pediatric and AYA oncology research (7)
- Adolescents and young adults: awareness, survivorship, transition and community (9)
- Global pediatric oncology gatherings spotlight collaboration, training and innovation (14)
- Other pediatric oncology news: research, partnerships, advocacy and care (24)
- All Other Stories
ACS launches open‑access journal centralizing pediatric and AYA oncology research
Adolescents and young adults: awareness, survivorship, transition and community
Global pediatric oncology gatherings spotlight collaboration, training and innovation
Other pediatric oncology news: research, partnerships, advocacy and care
All Other Stories
What are motor skills? Evidence‑based ways to support children's fine and gross motor development
medicalxpress - Motor skills are foundational for a lifetime of movement. For children, they play a vital role not only in facilitating physical activity levels but also for cognitive and socio-emotional development and school readiness.
AI Summary: New guidance summarizes evidence-based strategies to strengthen young children's fine and gross motor development, offering practical activities, screening cues and professional supports for parents and educators. The reporting emphasizes early intervention, play-based approaches and simple at-home exercises that can set the stage for healthier development without expensive gadgets or miracle fixes.
Cancer Risk Is Significantly Higher for Adults Who Never Married, Large Study Finds
oncodaily - Analysis of 4 million cases finds higher cancer rates across most types, especially for preventable cancers. Adults who have never been married face a significantly higher risk of developing cancer […]
AI Summary: A large observational analysis found that adults who never married have a significantly higher cancer risk compared with married peers, after adjusting for common confounders. Researchers highlight social, behavioral and access‑to‑care factors as possible contributors, suggesting that relationship status may serve as a marker for targeted prevention and support interventions.
- Lifestyle, sleep and fertility linked to cancer risk (3)
- Never-married adults face significantly higher cancer risk (3)
- Place, education and loneliness drive cancer disparities (3)